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of dietary fatty acids. The expression of genes involved in 
several lipid metabolic processes, as well as fish health and 
immune response, in both liver and anterior intestine were 
altered in fish fed the GM-derived oils. This showed a simi-
lar pattern to that observed in WCO-fed fish reflecting the 
hybrid fatty acid profile of the new oils. Overall the data 
indicated that the GM-derived oils could be suitable alter-
natives to dietary FO in sea bream.
Keywords Sea bream · Genetically modified · Camelina · 
Sustainable feeds
Abbreviations
ACTB  β Actin
ADC  Apparent digestibility coefficient
ARA  Arachidonic acid
CASP  Caspase
CPT  Carnitine palmitoyltransferase 1
CYTB  Cytochrome b
DCO  EPA + DHA Camelina oil
DHA  Docosahexaenoic acid
DPA  Docosapentaenoic acid
ECO  EPA-Camelina oil
ELF1α  Elongation factor 1α
ELOVL  Fatty acid elongase
EPA  Eicosapentaenoic acid
FABP2  Fatty acid binding protein 2
FADS2  Fatty acyl desaturase 2
FAME  Fatty acid methyl esters
FCR  Feed conversion ratio
FM  Fish meal
FO  Fish oil
GC  Gas–liquid chromatography
GM  Genetically modified
HL  Hepatic lipase
Abstract Omega-3 (n-3) long-chain polyunsaturated fatty 
acids (LC-PUFA) are essential components of the diet of 
all vertebrates. The major dietary source of n-3 LC-PUFA 
for humans has been fish and seafood but, paradoxically, 
farmed fish are also reliant on marine fisheries for fish meal 
and fish oil (FO), traditionally major ingredients of aqua-
feeds. Currently, the only sustainable alternatives to FO 
are vegetable oils, which are rich in C18 PUFA, but devoid 
of the eicosapentaenoic (EPA) and docosahexaenoic acids 
(DHA) abundant in FO. Two new n-3 LC-PUFA sources 
obtained from genetically modified (GM) Camelina sativa 
containing either EPA alone (ECO) or EPA and DHA 
(DCO) were compared to FO and wild-type camelina oil 
(WCO) in juvenile sea bream. Neither ECO nor DCO had 
any detrimental effects on fish performance, although final 
weight of ECO-fed fish (117 g) was slightly lower than that 
of FO- and DCO-fed fish (130 and 127 g, respectively). 
Inclusion of the GM-derived oils enhanced the n-3 LC-
PUFA content in fish tissues compared to WCO, although 
limited biosynthesis was observed indicating accumulation 
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HSI  Hepatosomatic index
IL  Interleukin
K  Condition factor
LC-PUFA  Long chain polyunsaturated fatty acid(s)
LPCAT  Lysophosphatidylcholine acyltransferase
LPL  Lipoprotein lipase
LTB4  Leukotriene B4
MUFA  Monounsaturated fatty acid(s)
n-3  Omega 3
n-6  Omega 6
n.d.  Not determined
NMDS  Non-metric multidimensional scaling plot
NPTII  Kanamycin resistance gene
NTC  Non-template control
PCA  Principal component analysis
PCNA  Proliferating cell nuclear antigen
PGE2  Prostaglandin E2
PPARα  Peroxisome proliferator-activated receptor α
PUFA  Polyunsaturated fatty acid(s)
SAFA  Saturated fatty acid(s)
SGR  Specific growth rate
SREBP  Sterol regulatory element binding protein 1
TAG  Triacylglycerol(s)
VLC-FA  Very long chain fatty acid(s)
VO  Vegetable oil(s)
VSI  Viscerosomatic index
WCO  Wild-type Camelina oil
Introduction
Fish is considered as the main source of the beneficial 
omega-3 (n-3) long-chain polyunsaturated fatty acids (LC-
PUFA) eicosapentaenoic and docosahexaenoic acids, EPA 
(20:5n-3) and DHA (22:6n-3), respectively. These LC-
PUFA play important roles in neural development, immune 
and inflammatory responses as well as having beneficial 
effects in certain pathologies such as those affecting the 
cardiovascular and neurological systems or some types of 
cancers [1–5]. According to estimations of the International 
Society for the Study of Fatty acids and Lipids (ISSFAL), a 
daily intake of 500 mg of EPA and DHA is recommended 
for optimum cardiovascular health [6]. In a world where the 
global population is expected to grow to reach 9.6 billion 
people by 2050 [7], more than 1.7 million metric tonnes of 
EPA + DHA would be necessary to cover annual human 
requirements. This quantity is not met by the actual total 
global supply of n-3 LC-PUFA and thus there is a large gap 
between supply and demand [8, 9].
Farmed fish and seafood accounted for 44.1 % of total 
production (including for non-food uses) from capture fish-
eries and aquaculture in 2014, up from 42.1 % in 2012 and 
31.1 % in 2004 [7]. Although fish farming contributes to the 
global n-3 LC-PUFA production in order to meet human 
dietary requirements, the marine ingredients, fish meal and 
oil (FM and FO, respectively) are still, almost exclusively, 
the only raw materials in aquafeeds that, in turn, can supply 
n-3 LC-PUFA to farmed fish. The use of high levels of FM 
and FO to maintain n-3 LC-PUFA levels in farmed fish is 
not a sustainable practice as they are finite (on an annual 
basis) and limited resources [9]. Sustainable alternatives to 
FO used at present are vegetable oils (VO), which are rich 
in C18 but lack n-3 LC-PUFA, which in turn reduces the 
proportions of EPA and DHA in farmed fish, and does not 
significantly increase global production of n-3 LC-PUFA 
[9]. Obtaining alternative sources of n-3 LC-PUFA from 
other marine organisms such as microalgae or zooplank-
ton (krill or copepods) poses significant technological and 
economic challenges and there are no currently feasible 
alternatives for mass supply [9]. Therefore, it is clear that 
completely new, de novo sources of EPA and DHA are 
required. In this respect, metabolic engineering of oilseed 
crops such as Camelina sativa or false flaxseed provides a 
currently viable option to deliver n-3 LC-PUFA in the place 
of fish oil [10–12]. By the insertion of cassettes containing 
five or seven fatty acyl desaturase and elongase genes from 
several algae species, genetically modified (GM) Camelina 
is capable of producing EPA or both EPA and DHA in their 
seeds [10]. Recent studies have successfully demonstrated 
the feasibility of using both the high-EPA and EPA + DHA 
oils as substitutes for FO in feeds for post-smolt Atlantic 
salmon (Salmo salar) without compromising fish growth or 
health [13–15].
Total replacement of FO in salmonids has been shown 
to be feasible without compromising fish performance, 
although a reduction in tissue n-3 LC-PUFA was observed 
due to reduced dietary intake and limited biosynthesis 
[16–18]. In contrast, total substitution of FO by VO in gilt-
head sea bream (Sparus aurata) feeds significantly reduced 
fish performance [19] and greatly altered fatty acid profile 
of bream tissues [20] given their incomplete LC-PUFA 
biosynthesis pathway [21, 22]. In this context, the aim of 
the present study was to evaluate the new GM Camelina-
derived oils that contain features of both marine fish (n-3 
LC-PUFA) and terrestrial plant (high levels of C18 fatty 
acids) oils as substitutes for FO in feeds for a marine tele-
ost species that have a very limited LC-PUFA biosynthesis 
capacity from C18 PUFA [22]. The specific objectives were 
to evaluate the efficacy of the high-EPA and EPA + DHA 
oils as replacements for dietary FO in feeds for gilthead sea 
bream juveniles in terms of growth, feed efficiency, health 
and welfare, and nutritional quality of the fish focussing 
particularly on tissue levels of EPA and DHA. Additionally, 
assessment of the expression of genes of lipid metabolism 
as well as molecular markers of health and immune func-
tion was also performed.
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Materials and Methods
Diets and Feeding Trial
Four isonitrogenous and isoenergetic diets were formu-
lated to contain 50 g/kg crude protein and 11 g/kg crude 
lipid, and manufactured at BioMar Tech-Centre (Brande, 
Denmark). The four feeds were produced by vacuum coat-
ing identical dry basal extruded pellets with either fish 
oil (FO), wild-type Camelina oil (WCO), EPA-Camelina 
oil (ECO) or EPA + DHA-Camelina oil (DCO) and were 
named according to the oils used (Table 1). ECO and DCO 
oils were produced as previously described [10, 13, 15]. 
In line with commercial practice, non-defatted fishmeal 
was employed as the major protein source to ensure EFA 
requirements were met [23], and yttrium oxide was added 
(0.5 g/kg) as an inert marker for calculation of lipid and 
fatty acid digestibility.
A total of 420 juvenile gilthead sea bream with an aver-
age body weight of 55.5 ± 0.4 g (mean ± SD) were dis-
tributed into 12 seawater tanks (35 per tank) and fed one 
of the four experimental feeds in triplicate for 11 weeks. 
The experimental system comprised 500 L tanks sup-
plied by flow-through seawater (9 L/min) at ambient tem-
perature that averaged 20.3 ± 0.6 °C. Experimental feeds 
were delivered until apparent satiation by hand-feeding 
three times a day with uneaten feed collected 30 min later 
in order to determine accurate feed efficiency. Collected 
feed was placed in an oven (110 °C) until constant weight 
was achieved in order to calculate feed intake based on 
initial moisture content. All procedures were conducted in 
accordance with the regulations set forward by the Spanish 
RD 53/2013 (BOE 8th February 2013) and the Directive 
2010/63/EU of the European Parliament and of the Council 
of 22 September 2010 on the protection of animals used for 
scientific purposes. The experiment was subjected to ethi-
cal review by the Animal Welfare and Bioethical Commit-
tee at the University of Las Palmas de Gran Canaria (Ref 
007/202 CEBA ULPGC).
Sample Collection and Digestibility
After 11 weeks of feeding, fish were not fed for 48 h prior 
to being sampled. All fish were anaesthetised with clove oil 
and weighed and their length measured. Ten fish for bio-
metric measurements (hepato-somatic and viscero-somatic 
indices) and tissue analyses were killed by overdose with 
clove oil. Samples of anterior intestine, liver, gills, flesh 
and brain from 3 fish per tank were immediately frozen 
Table 1  Formulations, proximate and fatty acid compositions (% of 
fatty acids) of the experimental feeds
n.d. not detected, WCO wild-type Camelina oil feed
a
 Fatty acid compositions of the oils were provided previously [13, 
15]
b
 Includes 15:0, 22:0 and 24:0
c
 Includes 16:1n-9, 20:1n-11, 20:1n-7, 22:1n-9 and 24:1n-9
d
 Includes 22:4n-6 and 22:5n-6
e
 Includes C16 PUFA. DCO, feed containing EPA + DHA oil from 
transgenic Camelina; ECO, feed containing high-EPA oil from trans-
genic Camelina; FO, fish oil feed; LC- PUFA, long-chain polyunsatu-
rated fatty acids (sum of 20:4n-3, 20:5n-3 22:5n-3 and 22:6n-3)
FO WCO ECO DCO
Feed ingredients (%)
 Fish meal, NA LT 70 24.43 24.43 24.43 24.43
 Fish meal, SA 68 Superprime 24.43 24.43 24.43 24.43
 Soy protein concentrate (60 %) 9.79 9.79 9.79 9.79
 Maize gluten 14.66 14.66 14.66 14.66
 Wheat 14.66 14.66 14.66 14.66
 Fish oila 11.53 – – –
 Wild-type Camelina oila – 11.53 – –
 EPA-Camelina oila – – 11.53 –
 EPA + DHA-Camelina oila – – – 11.53
 Vitamins/minerals 0.45 0.45 0.45 0.45
Yttrium oxide 0.05 0.05 0.05 0.05
Analysed composition
 Dry matter (%) 93.78 93.57 94.05 93.94
 Crude protein (%) 50.00 50.72 50.23 50.53
 Crude lipid (%) 18.47 18.27 17.90 17.93
 Ash 8.37 8.33 8.45 8.15
Fatty acid composition (mol%)
 Ʃ saturatedb 32.60 15.89 18.84 19.71
 Ʃ monounsaturatedc 27.55 31.93 21.25 22.23
 18:2n-6 5.61 18.25 21.90 19.72
 20:2n-6 0.15 1.31 1.46 0.78
 20:3n-6 0.13 n.d 1.17 0.82
 20:4n-6 1.09 0.22 2.44 1.53
 22:4n-6 0.07 n.d. n.d. n.d.
 Ʃ n-6 PUFAd 7.56 19.85 28.16 26.56
 18:3n-3 1.03 23.78 8.68 10.96
 20:3n-3 0.06 0.89 0.80 0.52
 20:4n-3 0.55 0.14 2.15 1.66
 20:5n-3 13.15 2.31 13.53 6.24
 22:5n-3 1.39 0.25 0.78 1.21
 22:6n-3 9.67 3.91 4.20 6.88
 Ʃ n-3 PUFA 27.86 31.84 31.25 30.99
 Ʃ PUFAe 39.85 52.18 59.91 58.06
 Total n-3 LC-PUFA 24.75 6.61 20.66 15.99
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and stored at −70 °C prior to total lipid extraction and 
fatty acid analyses. Further samples of liver and anterior 
intestine were collected from six fish per treatment (two 
per tank) and stabilised in RNAlater® (Sigma, Poole, UK) 
prior to RNA extraction. All remaining fish were fed for a 
further week prior to faeces being collected according to 
the method described by [24]. Briefly, fish were killed by 
overdose with clove oil 7 h after being fed and faecal sam-
ples collected after dissecting the rectum of the fish. Fae-
cal samples were pooled by tank and stored −20 °C prior 
to lipid and fatty acid analysis. The apparent digestibility 
coefficient (ADC) of lipid and selected fatty acids was 
calculated as: 100 − [100 × (Y2O3 concentration in feed/
Y2O3 concentration in faeces) × (lipid or fatty acid concen-
tration in faeces/lipid or fatty acid concentration in feed)]. 
The concentration of individual fatty acids in diets and fae-
ces were calculated based on the relative proportion of each 
fatty acid compared with a known amount of the internal 
standard (17:0) added and the total lipid content deter-
mined in the samples. Yttrium was estimated after acid 
digestion of the samples via Inductively Coupled Plasma 
Mass Spectrometry (Thermo Scientific, XSeries2 ICP-MS, 
USA) using argon and hydrogen as carrier gas.
Proximate Composition
Diets and whole fish were ground before determination of 
proximate composition according to standard procedures 
[25]. Fish were pooled per tank (n = 3) and freeze-dried 
until further analysis whereas three technical replicates of 
feeds (single batch production) were analysed. Moisture 
contents were obtained after drying in an oven at 110 °C 
for 24 h and ash content determined after incineration at 
600 °C for 16 h. Crude protein was measured by determin-
ing nitrogen content (N × 6.25) using automated Kjeldahl 
analysis (Tecator Kjeltec Auto 1030 analyser, Foss, War-
rington, UK) and crude lipid content determined gravimet-
rically after Soxhlet lipid extraction (Tecator Soxtec system 
2050 Auto Extraction apparatus).
Faeces and Tissue Lipid Content and Fatty Acid 
Composition
Samples of faeces, muscle (flesh), liver, gills, anterior 
intestine and brain from three fish per tank were prepared 
as pooled homogenates (n = 3 per treatment) and total 
lipid extracted by homogenising in chloroform/methanol 
(2:1, v/v) using an Ultra-Turrax tissue disrupter (Fisher 
Scientific, Loughborough, UK), with content determined 
gravimetrically [26]. Fatty acid methyl esters (FAME) 
were prepared from total lipid by acid-catalysed transes-
terification at 50 °C for 16 h [27], and FAME extracted 
and purified as described previously [28]. FAME were 
separated and quantified by gas-liquid chromatography 
using a Fisons GC-8160 (Thermo Scientific, Milan, Italy) 
equipped with a 30 m × 0.32 mm i.d. × 0.25 μm ZB-wax 
column (Phenomenex, Cheshire, UK), on-column injec-
tor and a flame ionisation detector. Data were collected 
and processed using Chromcard for Windows (version 
2.01; Thermoquest Italia S.p.A., Milan, Italy). Individual 
FAME were identified by comparison to known standards 
and published data [28] and results expressed as mole 
percentage.
Histological Analysis
Samples of liver and intestine from 2 fish per tank (n = 6 
per treatment) were fixed in 4 % buffered formalin dehy-
drated through graded alcohol, then xylene, and finally 
embedded in paraffin wax. The paraffin blocks were sec-
tioned at 3 μm and stained with haematoxylin and eosin 
[29] before blind examination under a light microscope. 
Stained sections of liver were assessed for cytoplasmic 
lipid vacuolization and peripancreatic fat infiltration using 
a four graded examination scheme: 0, not observed; 1, few; 
2, medium; 3, severe. Posterior intestine sections were 
examined for integrity of the intestinal mucosa and the 
presence of any inflammatory response.
RNA Extraction
Liver and anterior intestine from six individual fish per die-
tary treatment were homogenised in 1 ml of TriReagent® 
(Sigma-Aldrich, Dorset, UK) RNA extraction buffer using 
a bead tissue disruptor (Bio Spec, Bartlesville, Oklahoma, 
USA). Total RNA was isolated following the manufac-
turer’s instructions and quantity and quality determined by 
spectrophotometry using a Nanodrop ND-1000 (Labtech 
Int., East Sussex, UK) and electrophoresis using 250 ng 
of total RNA in a 1 % agarose gel. cDNA was synthesised 
using 2 μg of total RNA and random primers in 20 μl reac-
tions and the High capacity reverse transcription kit with-
out RNase inhibiter according to the manufacturer’s proto-
col (Applied Biosystems, Warrington, UK). The resulting 
cDNA was diluted 20-fold with milliQ water. Expression 
of genes of interest was determined by quantitative PCR 
(qPCR) from fish fed all diets (Table 2). Results were nor-
malised using reference genes, elongation factor 1α (elf1α) 
and beta-actin (actb), as their expression did not vary 
among treatments. The efficiency of the primers for each 
gene was previously evaluated by serial dilutions to ensure 
that it was close to 100 %. qPCR was performed using a 
Biometra TOptical Thermocycler (Analytik Jena, Goettin-
gen, Germany) in 96-well plates in duplicate 20-μl reac-
tion volumes containing 10 μl of Luminaris Color HiGreen 
qPCR Master Mix (Thermo Scientific, Hemel Hempstead, 
Lipids 
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UK), 1 μl of the primer corresponding to the analysed gene 
(10 pmol), 3 μl of molecular biology grade water and 5 μl 
of cDNA, with the exception of the reference genes, which 
were determined using 2 μl of cDNA. In addition amplifi-
cations were carried out with a systematic negative control 
(NTC-non template control) containing no cDNA. Standard 
amplification parameters contained a UDG pre-treatment at 
50 °C for 2 min, an initial denaturation step at 95 °C for 
10 min, followed by 35 cycles: 15 s at 95 °C, 30 s at 60 °C 
and 30 s at 72 °C.
Table 2  Details of primer used for qPCR or PCR analysis
fads2 fatty acid desaturase 2, elovl4 fatty acid elongase 4, elovl5 fatty acid elongase 5, lpcat1 lysophosphatidylcholine acyltransferase 1, FABP2 
fatty acid binding protein 2, hl hepatic lipase, lpl lipoprotein lipase, cpt1a carnitine palmitoyltransferase 1A liver isoform, cpt1b Carnitine pal-
mitoyltransferase 1b muscle isoform, srebp1 sterol regulatory element binding protein 1, PPARα peroxisome proliferator-activated receptor α, 
PPARγ peroxisome proliferator-activated receptor γ, casp3 caspase 3, pcna proliferating cell nuclear antigen, il8 interleukin 8, actb β-actin, ef1α 
elongation factor 1, nptII neomycin phosphotransferase II, cytb cytochrome b
Aim Transcript Primer sequence (5′ → 3′) Amplicon (bp) Ta (°C) Accession no.
qPCR fads2 F: GCAGGCGGAGAGCGACGGTCTGTTCC 72 60 AY055749
R: AGCAGGATGTGACCCAGGTGGAGGCAGAAG
elovl4 F: CGGTGGCAATCATCTTCC 79 60 JX975701
R: TCAACTGGCTGTCTGTGT
elovl5 F: CCTCCTGGTGCTCTACAAT 112 60 AY660879
R: GTGAGTGTCCTGGCAGTA
lpcat1 F: CGTGATAGCCTTATCTGTCGTATGC 90 60 JQ390612
R: CCGTCCTCCTCTGCCTCAA
FABP2 F: CGAGCACATTCCGCACCAAAG 93 60 AM957164
R: CCCACGCACCCGAGACTTC
hl F: TTGTAGAAGGTGAGGAAAACTG 131 60 EU254479
R: GCTCTCCATCAGACCATCC
lpl F: CGTTGCCAAGTTTGTGACCTG 192 60 AY495672
R: AGGGTGTTCTGGTTGTCTGC
cpt1a F: GTGCCTTCGTTCGTTCCATGATC 82 60 JQ308822
R: TGATGCTTATCTGCTGCCTGTTTG
cpt1b F: CCACCAGCCAGACTCCACAG 78 60 DQ866821
R: CACCACCAGCACCCACATATTTAG
srebp1 F: AGGGCTGACCACAACGTCTCCTCTCC 77 60 JQ277709
R: GCTGTACGTGGGATGTGATGGTTTGGG
PPARα F: TCTCTTCAGCCCACCATCCC 116 60 AY590299
R: ATCCCAGCGTGTCGTCTCC
PPARγ F: CGCCGTGGACCTGTCAGAGC 103 60 AY590304
R: GGAATGGATGGAGGAGGAGGAGATGG
casp3 F: CCAGTCAGTCGAGCAGATGA 113 60 EU722334
R: GAACACACCCTCGTCTCCAT
pcna F: GATGTGGAGCAGCTGGGTAT 205 60 FG263675
R: TGTCTACGTTGCTGGTCTGG
il8 F: CAGCAGAGTCTTCATCGTCACTATTG 66 60 JX976619
R: AGGCTCGCTTCACTGATGG
actb F: TCCTGCGGAATCCATGAGA 50 60 X89920
R: GACGTCGCACTTCATGATGCT
ef1a F: ACGTGTCCGTCAAGGAAATC 109 60 AF184170
R: GGGTGGTTCAGGATGATGAC
PCR nptII F: CTCACCTTGCTCCTGCCGAGA 215 60 KJ081792.1
R: CGCCTTGAGCCTGGCGAACAG
cytb F: CCGCTTCTTTGCCTTCCATT 219 57 NC_024236.1
R: AGATTAGGGGCGAATAGGGC
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Tracking of the nptII Gene in Gilthead Sea Bream 
Liver, Intestine and Muscle
Genomic DNA was extracted from fish flesh, pyloric 
caeca and liver using REALPURE extraction kit (Valen-
cia, Spain) according to the manufacturer’s instructions. 
Briefly, tissue samples were incubated in 300 μl of lysis 
solution overnight at 55 °C with 3 μl of Proteinase K. 
Following the incubation, samples were cooled down and 
RNase treatment performed (37 °C for 60 min). After pro-
tein precipitation, DNA was precipitated by adding 600 μl 
of isopropanol and hydrated with 5 mM Tris. Total DNA 
was quantified by spectrophotometry and quality deter-
mined by electrophoresis as described above. Two primers 
pairs targeting an endogenous sea bream gene (cytochrome 
b; cytb) and a transgene marker for ECO – plants (Kanamy-
cin resistance gene, nptII) were used (Table 2). Fifty ng of 
extracted DNA was used in PCR amplifications that were 
performed in a final volume of 10 μl, containing 5 μl of 
MyTaq™ HS Mix (Bioline, London, UK). Each set of PCR 
included a positive control (DNA from genetically modi-
fied-Camelina) and a non-template control (NTC).
Statistical Analysis
All data are mean ± SE (n = 3) unless otherwise specified. 
Percentage data were subjected to arcs in square-root trans-
formation prior to statistical analyses. Data were tested for 
normality and homogeneity of variances with Levene’s test 
prior to one-way analysis of variance followed by a Tukey–
Kramer HSD multiple comparisons of means. A non-metric 
multidimensional scaling plot (NMDS) was performed in order 
to separate the fatty acid profile of the five evaluated tissues. 
Stress values <0.05 indicated an excellent representation of the 
clusters and <0.1 and <0.2 indicated good and potentially use-
ful plots respectively. All statistical analyses were performed 
using SPSS software (IBM SPSS Statistics 19; SPSS Inc., Chi-
cago, IL, USA), excepting the NMDS analysis (PAST) [30].
Results
Fish Performance
Sea bream fed all the experimental diets more than dou-
bled in weight after 11 weeks feeding, and no mortalities 
were recorded (Table 3). Fish fed ECO displayed the lowest 
final weight and total length among the dietary treatments, 
although not different to fish fed WCO, with highest growth 
achieved in fish fed the FO and DCO feeds (Table 3). Final 
weights reflected feed intake, which was highest in fish 
fed FO and DCO, lowest in fish fed ECO and intermedi-
ate in fish fed WCO. There were no significant differences 
in weight gain or specific growth rate (SGR) other than it 
being slightly lower in fish fed ECO compared to fish fed FO 
(Table 3). There were no differences in the hepatosomatic or 
Table 3  Growth performance, survival, feed utilization and basic and whole body proximate composition (% dry weight) of gilthead sea bream 
after 11 weeks of feeding the experimental diets
Data are expressed as mean ± SD (n = 3). Different superscript letters within a row denote significant differences among diets as determined by 
one-way ANOVA with Tukey’s comparison test (p < 0.005)
DCO feed containing EPA + DHA oil from transgenic Camelina, ECO feed containing high-EPA oil from transgenic Camelina, FI feed intake, 
FO fish oil feed, HSI hepatosomatic index, k condition factor, SGR specific growth rate, VSI viscerosomatic index, WCO wild-type Camelina oil 
feed
FO WCO ECO DCO
Initial weight (g) 55.4 ± 6.5 55.8 ± 6.5 55.0 ± 7.2 56.0 ± 6.1
Final weight (g) 129.9 ± 10.8a 123.2 ± 15.5ab 117.3 ± 13.6b 126.9 ± 20.0a
Final length (cm) 18.3 ± 0.5a 18.0 ± 0.7ab 17.8 ± 0.6b 18.3 ± 0.9a
Weight gain (g) 74.5 ± 2.3 73.5 ± 9.7 62.2 ± 2.6 71.1 ± 4.1
HSI 1.4 ± 0.3 1.6 ± 0.3 1.4 ± 0.2 1.5 ± 0.2
VSI 8.0 ± 1.4 8.0 ± 1.0 7.8 ± 0.5 7.9 ± 1.0
FI (g/tank) 3482.1 ± 215.5a 3108.1 ± 88.9ab 2898.1 ± 130.3b 3465.9 ± 127.9a
FCR 1.3 ± 0.1 1.2 ± 0.2 1.3 ± 0.1 1.4 ± 0.1
SGR 1.0 ± 0.1a 1.0 ± 0.2ab 0.9 ± 0.1b 1.0 ± 0.2ab
k 1.2 ± 0.1 1.1 ± 0.2 1.1 ± 0.1 1.1 ± 0.2
Whole body composition (% dry wt.)
 Crude protein 47.5 ± 0.7 48.0 ± 1.7 49.6 ± 1.3 49.3 ± 0.5
 Crude lipid 35.7 ± 2.0 38.4 ± 1.6 38.5 ± 1.2 37.3 ± 0.3
 Ash 9.8 ± 0.9 9.8 ± 0.6 9.8 ± 0.5 9.9 ± 0.2
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viscerosomatic index (HSI and VSI, respectively), although 
values tended to be lowest in fish fed DCO and ECO 
(p = 0.576 and 0.869 respectively). No differences were 
observed in other fish performance parameters including 
feed conversion ratio (FCR) or k condition factor (Table 3).
Lipid and Fatty Acid Digestibility
The apparent digestibility coefficients (ADC) were calcu-
lated for lipids and fatty acids using yttrium oxide as an inert 
marker. There were no significant differences in crude lipid 
ADC among the dietary treatments (Table 4). Figure 1 repre-
sents the analysed fatty acid composition of feeds and faeces 
in order to compare which fatty acid groups were preferen-
tially digested and absorbed (i.e. those found in lower amounts 
in faeces). There was a trend for higher proportions of satu-
rated fatty acids (SAFA) in faeces relative to the feeds, with 
the ADC for SAFA varying between around 81 and 87 %, 
generally slightly lower than the ADCs for the other fatty acids 
(Table 4). In contrast, proportions of PUFA in the faeces were 
generally lower compared to proportions in feeds with ADCs 
ranging from 93 to almost 97 %, whereas proportions of mon-
ounsaturated fatty acid (MUFA) were similar in diet and fae-
ces with ADC ranging from around 83 to 92 % (Fig. 1). Some 
variations were found between feeds, with ADC of SAFA 
being highest in fish fed FO and lowest in fish fed ECO, with 
ADC of MUFA being higher in fish fed ECO and DCO com-
pared to fish fed FO (Table 4). Similarly, ADC of 18:2n-6 
and n-6 PUFA were higher in fish fed DCO compared to fish 
fed FO. Digestibility was highest with n-3 PUFA generally 
although ADC for EPA was lowest in WCO, although not dif-
ferent to that of ECO. Regarding DHA, FO and DCO showed 
the highest ADC, being over 96 % (Table 4).
Whole Fish Composition
No differences were found in any of the analysed compo-
nents among fish fed the four dietary treatments (Table 3). 
However, there were trends for higher lipid content in fish 
fed the vegetable-based feeds (p = 0.186), and increased 
protein in fish fed the ECO and DCO feeds containing oil 
from transgenic Camelina (p = 0.202).
Tissue Lipid Content
The lipid content of flesh (muscle) varied between around 
3 and 4.5 % but diet had no significant effect (Table 5). In 
contrast, the lipid content of liver was higher in fish fed 
WCO than in fish fed FO with fish fed the oils derived 
from transgenic Camelina showing intermediate values 
(Table 6). Diet had no significant effect on the lipid content 
of other tissues including gill (Table 6), anterior intestine 
and brain (Table 7).
Tissue Fatty Acid Compositions
Muscle (Flesh)
No differences were observed in the proportions of total n-3 
PUFA in muscle (p = 0.508), although clear differences 
Table 4  Apparent digestibility coefficient (ADC) of lipid and fatty 
acids in gilthead sea bream fed the four experimental diets differing 
in oil source
Data expressed as mean ± SD (n = 3). Different superscript letters 
within a row denote significant differences among diets. Statistical 
differences were determined by one-way ANOVA with Tukey’s com-
parison test (p < 0.05)
DCO feed containing EPA + DHA oil from transgenic Camelina, 
ECO feed containing oil from transgenic Camelina, FO fish oil feed, 
WCO wild-type Camelina oil feed
A
 Includes 22:0 and 24:0
B
 Includes 16:1n-9 and 24:1n-9
C
 Includes 22:4n-6 and 22:5n-6
D
 Includes C16 PUFA
FO WCO ECO DCO
Lipid ADC 83.8 ± 4.1 81.2 ± 6.3 80.5 ± 8.0 85.8 ± 5.2
14:0 88.8 ± 3.4 80.2 ± 10.3 84.0 ± 8.5 87.1 ± 6.1
15:0 99.0 ± 0.2 97.7 ± 0.9 97.5 ± 1.1 98.2 ± 0.6
16:0 83.3 ± 4.0 78.5 ± 8.0 78.5 ± 8.8 83.4 ± 5.5
18:0 78.9 ± 3.9 75.8 ± 5.7 77.3 ± 0.2 78.5 ± 4.3
Total  
saturatedA
87.4 ± 1.3a 86.5 ± 1.4a 81.3 ± 0.4c 84.2 ± 0.5b
16:1n-7 89.4 ± 4.8 83.3 ± 5.0 90.2 ± 0.2 90.8 ± 1.4
18:1n-9 81.8 ± 8.3 82.9 ± 9.1 86.9 ± 8.1 84.7 ± 8.6
18:1n-7 86.2 ± 5.8 84.7 ± 6.7 86.2 ± 7.4 88.9 ± 6.1
20:1n-9 89.6 ± 4.0 89.8 ± 3.9 88.6 ± 6.3 92.7 ± 3.1
20:1n-7 87.4 ± 3.7 86.2 ± 4.6 89.0 ± 1.4 89.5 ± 3.4
22:1n-11 93.2 ± 1.6a 87.2 ± 4.5b 88.8 ± 1.5ab 92.3 ± 0.1a
22:1n-9 78.3 ± 7.9 83.1 ± 5.0 84.0 ± 2.7 84.7 ± 4.6
Total  
monoenesB
83.4 ± 1.2b 87.9 ± 3.5ab 89.6 ± 0.5a 91.9 ± 1.0a
18:2n-6 90.6 ± 2.9b 92.6 ± 2.3ab 95.0 ± 0.1ab 95.8 ± 0.6a
20:2n-6 88.8 ± 3.1 89.5 ± 4.3 93.2 ± 0.7 92.6 ± 4.0
20:4n-6 97.4 ± 0.1 92.9 ± 1.2 96.1 ± 2.3 95.6 ± 1.5
Total n-6 
PUFAC
92.1 ± 2.3b 94.0 ± 0.7ab 95.1 ± 0.1ab 96.1 ± 0.5a
18:3n-3 92.7 ± 2.0b 95.0 ± 1.8ab 96.4 ± 0.3a 97.1 ± 0.4a
18:4n-3 97.6 ± 0.4a 92.9 ± 2.0b 97.5 ± 0.1a 98.1 ± 0.3a
20:3n-3 96.0 ± 4.0 90.8 ± 3.5 94.4 ± 0.1 95.4 ± 0.5
20:4n-3 95.2 ± 1.1a 82.2 ± 5.1b 97.1 ± 0.1a 96.9 ± 0.3a
20:5n-3 98.2 ± 0.3a 95.5 ± 0.9b 97.3 ± 0.0ab 98.0 ± 0.1a
22:5n-3 93.4 ± 1.5a 80.4 ± 2.2b 87.8 ± 4.1ab 92.2 ± 5.1a
22:6n-3 96.8 ± 1.2a 93.6 ± 1.2b 93.6 ± 1.8b 96.6 ± 0.1a
Total n-3 
PUFA
97.4 ± 0.4a 95.0 ± 1.9b 96.6 ± 0.3ab 97.1 ± 0.3ab
Total PUFAD 96.4 ± 0.7a 93.0 ± 2.3b 95.9 ± 0.2ab 96.7 ± 0.4a
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were found in individual fatty acids (Table 5). The mole 
percentages of EPA were highest in fish fed FO and ECO, 
lowest in fish fed WCO and intermediate in fish fed DCO. 
Proportions of DHA were similar in fish fed FO and DCO 
and higher than in fish fed WCO, with fish fed ECO show-
ing intermediate values. Fish fed the FO and ECO diets 
displayed similar proportions of n-3 docosapentaenoic acid 
(DPA, 22:5n-3) in flesh, which were significantly higher 
than those found in fish fed WCO or DCO. The totals of 
EPA + DHA and EPA + DPA + DHA in fish fed all feeds 
varied in the rank order FO > ECO > DCO > WCO. The 
proportions of 18:2n-6 and total n-6 PUFA were higher in 
flesh of sea bream fed all the diets containing VO (WCO, 
ECO and DCO) compared to fish fed FO (Table 5). No 
differences were observed in total SAFA and total MUFA 
were higher in fish fed FO and WCO compared to fish fed 
the oils from transgenic Camelina.
Liver
The fatty acid profile of liver was similar to that of mus-
cle and mainly reflected dietary compositions. No differ-
ences were found in total n-3 PUFA among the four dietary 
treatments as low levels of n-3 LC-PUFA were associated 
with high levels of short chain precursors (Table 6). The 
percentages of EPA were similar and highest in fish fed 
FO and ECO, lowest in fish fed WCO and intermediate in 
fish fed DCO. Proportions of DHA were similar in fish fed 
FO and DCO and higher than in fish fed WCO, with fish 
fed ECO showing intermediate values. Again, the totals of 
EPA + DHA and EPA + DPA + DHA in fish fed all feeds 
were in the rank order FO > ECO > DCO > WCO. Pro-
portions of total n-6 PUFA were higher in liver of fish-fed 
ECO and DCO reflecting the higher dietary n-6 contents, 
particularly 18:2n-6 and arachidonic acid (ARA, 20:4n-6).
Gills
In general terms, gill fatty acid compositions mir-
rored dietary input, although some small differ-
ences were found (Table 6). Proportions of EPA var-
ied in the rank order FO = ECO > DCO > WCO, DHA 
in the rank order FO > DCO > ECO = WCO, and 
EPA + DHA and EPA + DPA + DHA in the rank order 
FO > ECO > DCO > WCO. 18:2n-6 was higher in gills 
of fish fed the VO diets compared to fish fed FO while 
ARA varied in the rank order ECO > DCO = FO > WCO 
(Table 6).
Anterior Intestine
Proportions of EPA, DHA and total EPA + DPA + DHA 
varied in anterior intestine with essentially the same pattern 
as described for gills (Table 7). However, total n-6 PUFA 
contents were higher in anterior intestine than in the other 
tissues analysed, particularly in fish fed the diets contain-
ing oil from transgenic Camelina due to higher levels of 
18:2n-6 and ARA.
Brain
The fatty acid composition of brain was least influenced by 
diet, with fewer individual fatty acids showing significant 
differences and the magnitude of differences being lower 
(Table 7). Specifically and importantly, DHA, EPA + DHA, 
EPA + DPA + DHA and EPA/DHA ratio did not vary 
between fish fed the different diets, and neither did 18:2n-6 
or the totals of n-3 PUFA, PUFA, SAFA and MUFA.
The non-metric multidimensional scaling (NMDS) plot 
clearly showed that tissue fatty acid compositions were 
affected by the dietary input rather than by tissue type with 
the exception of brain, which clustered in a different group 
(Fig. 2, stress 0.07). This was confirmed by the global R 
value and low p obtained (R = 0.481; p < 0.001) when com-
paring the feeds. Pair-wise R indicated that the segregation 
was strongest between fish fed FO and WCO (R = 0.711; 
p = 0.005), whereas the weakest separation was observed 
between fish fed the ECO and DCO diets (R = 0.233; 
p = 0.030). The tissue fatty acid profiles of fish fed the two 
transgenic-derived oils did not show high separation with 
WCO (R = 0.431 and 0.404, and p = 0.003 and 0.004 for 
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Fig. 1  Fatty acid compositions (mol%) of the four experimental 
feeds and faeces showing preferential order of absorption with differ-
ing degree of unsaturation of dietary fatty acids
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ECO and DCO, respectively). Tissue-wise, a weak segrega-
tion was observed (global R = 0.261; p = 0.008), although 
brain displayed a strong separation from other tissues (i.e. 
R = 1 for muscle and 0.958 for gill).
Tissue Histology
Fish fed the FO diet showed regular hepatocyte mor-
phology with large centrally located nuclei with few 
Table 5  Total lipid content 
(percentage of wet weight) 
and total lipid fatty acid 
composition (mol%) of muscle 
(flesh) of sea bream after 
feeding the experimental diets 
for 11 weeks
Data are expressed as mean ± SD (n = 3). Different superscript letters within a row denote significant dif-
ferences among diets as determined by one-way ANOVA with Tukey’s comparison test (p < 0.005)
DCO feed containing EPA + DHA oil from transgenic Camelina, DHA docosahexaenoic acid (22:6n-3); 
DPA, docosapentaenoic acid (22:5n-3), ECO feed containing high-EPA oil from transgenic Camelina, EPA 
eicosapentaenoic acid (20:5n-3), FO fish oil feed, WCO wild-type Camelina oil feed
A
 Includes 15:0, 22:0 and 24:0
B
 Includes 16:1n-9 and 24:1n-9
C
 Includes 22:5n-6
D
 Includes C16 PUFA
FO WCO ECO DCO
Lipid content (%) 4.5 ± 0.6 3.6 ± 0.6 2.9 ± 0.6 3.5 ± 0.5
Fatty acid composition
 14:0 4.6 ± 0.0a 3.0 ± 1.3ab 2.4 ± 0.1b 2.2 ± 0.1b
 16:0 19.6 ± 0.3 17.4 ± 2.5 16.5 ± 0.2 16.6 ± 0.3
 18:0 4.3 ± 0.2ab 4.1 ± 0.3b 4.6 ± 0.2ab 4.8 ± 0.3a
 20:0 0.2 ± 0.0b 0.4 ± 0.2b 0.7 ± 0.0a 0.6 ± 0.0a
 Total saturatedA 29.3 ± 0.3 25.2 ± 3.9 24.7 ± 0.3 24.7 ± 0.4
 16:1n-7 6.8 ± 0.1a 4.4 ± 2.1ab 3.3 ± 0.2b 3.2 ± 0.2b
 18:1n-9 19.9 ± 0.6a 20.2 ± 0.7a 17.1 ± 0.8b 17.7 ± 0.4b
 18:1n-7 3.4 ± 0.2a 2.5 ± 0.7ab 2.5 ± 0.0ab 2.4 ± 0.1b
 20:1n-11 0.3 ± 0.0a 0.2 ± 0.1b 0.2 ± 0.0b 0.2 ± 0.0b
 20:1n-9 1.4 ± 0.0 4.2 ± 2.4 3.2 ± 0.1 3.4 ± 0.1
 20:1n-7 0.2 ± 0.0 0.2 ± 0.0 0.3 ± 0.0 0.2 ± 0.0
 22:1n-11 1.2 ± 0.0a 1.0 ± 0.3ab 0.9 ± 0.0b 0.9 ± 0.0b
 22:1n-9 0.4 ± 0.0 1.0 ± 0.5 0.7 ± 0.0 0.7 ± 0.0
 Total monounsatu-
ratedB
34.9 ± 0.5a 35.0 ± 1.1a 29.2 ± 1.1b 30.0 ± 0.7b
 18:2n-6 6.6 ± 0.3b 11.1 ± 4.1a 14.6 ± 0.2a 13.6 ± 0.3a
 18:3n-6 0.2 ± 0.0c 0.2 ± 0.0c 0.6 ± 0.0b 1.8 ± 0.1a
 20:2n-6 0.2 ± 0.0b 0.8 ± 0.1ab 1.0 ± 0.0a 0.6 ± 0.0ab
 20:3n-6 0.2 ± 0.0b 0.3 ± 0.1b 0.9 ± 0.1a 1.0 ± 0.1a
 20:4n-6 0.9 ± 0.0bc 0.6 ± 0.3c 1.7 ± 0.2a 1.3 ± 0.1b
 22:4n-6 0.1 ± 0.0bc 0.1 ± 0.0c 0.2 ± 0.0a 0.1 ± 0.0b
 Total n-6 PUFAC 8.5 ± 0.3b 13.2 ± 4.3ab 19.2 ± 0.2a 18.7 ± 0.1a
 18:3n-3 1.2 ± 0.0d 12.1 ± 0.1a 4.6 ± 0.2c 5.8 ± 0.1b
 18:4n-3 1.1 ± 0.0b 0.6 ± 0.0d 0.7 ± 0.0c 1.7 ± 0.1a
 20:3n-3 0.1 ± 0.0 0.6 ± 0.5 0.5 ± 0.0 0.4 ± 0.0
 20:4n-3 0.7 ± 0.0b 0.6 ± 0.1b 1.4 ± 0.0a 1.5 ± 0.1a
 20:5n-3 8.0 ± 0.1a 4.5 ± 3.1c 7.8 ± 0.3a 5.7 ± 0.1b
 22:5n-3 2.9 ± 0.1a 1.3 ± 0.1c 2.9 ± 0.2a 2.2 ± 0.1b
 22:6n-3 10.8 ± 0.1a 7.4 ± 0.9c 8.3 ± 0.9bc 9.7 ± 0.6ab
 Total n-3 PUFA 25.2 ± 0.3 25.6 ± 1.4 26.3 ± 1.2 26.1 ± 0.5
 Total PUFAD 35.8 ± 0.6c 39.8 ± 4.1bc 46.1 ± 1.3a 45.3 ± 0.5ab
 EPA + DHA 18.8 ± 0.2a 12.0 ± 3.2b 16.1 ± 1.2ab 14.4 ± 0.5ab
 EPA/DHA 0.7 ± 0.0 0.6 ± 0.4 0.9 ± 0.1 0.5 ± 0.0
 EPA + DPA + DHA 21.7 ± 0.2a 13.3 ± 3.3b 19.0 ± 1.3a 16.6 ± 0.6ab
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Table 6  Total lipid content 
(percentage of wet weight) and 
fatty acid compositions (mol%) 
of total lipid of liver and gills of 
sea bream
Data are expressed as mean ± SD (n = 3). Different superscript letters within a row denote significant dif-
ferences among diets as determined by one-way ANOVA with Tukey’s comparison test (p < 0.005)
DCO feed containing EPA + DHA oil from transgenic Camelina, DHA docosahexaenoic acid (22:6n-3), 
DPA docosapentaenoic acid (22:5n-3), ECO feed containing high-EPA oil from transgenic Camelina, EPA 
eicosapentaenoic acid (20:5n-3), FO fish oil feed, WCO wild-type Camelina oil feed
A
 Includes 15:0, 22:0 and 24:0
B
 Includes 16:1n-9 and 24:1n-9
C
 Includes 22:5n-6
D
 Includes C16 PUFA
FO WCO ECO DCO
Liver
 Lipid content 7.6 ± 1.6b 10.4 ± 1.6a 8.8 ± 0.1ab 8.6 ± 0.6ab
 Fatty acid composition
  16:0 20.8 ± 0.4a 18.1 ± 1.3b 16.7 ± 0.9b 18.1 ± 1.3b
  Total saturatedA 31.7 ± 0.7a 26.5 ± 1.8b 25.9 ± 1.5b 27.7 ± 1.8b
  18:1n-9 21.2 ± 1.0ab 23.6 ± 1.8a 17.9 ± 1.4b 18.6 ± 1.8b
  Total monounsaturatedB 35.1 ± 1.7ab 37.3 ± 2.4a 29.2 ± 1.9b 30.2 ± 2.4b
  18:2n-6 4.6 ± 0.7c 10.9 ± 0.7b 13.6 ± 0.6a 12.0 ± 0.7ab
  20:4n-6 1.3 ± 0.2b 0.6 ± 0.2c 2.2 ± 0.3a 1.7 ± 0.2ab
  22:4n-6 0.1 ± 0.1bc 0.0 ± 0.0c 0.2 ± 0.0a 0.2 ± 0.0a
  Total n-6 PUFAC 7.0 ± 0.6c 13.8 ± 0.9b 19.4 ± 1.1a 17.9 ± 0.9a
  18:3n-3 0.8 ± 0.1c 9.8 ± 0.5a 4.2 ± 0.3b 5.2 ± 0.5b
  20:5n-3 7.4 ± 0.4a 2.1 ± 0.6c 6.9 ± 0.7a 3.9 ± 0.6b
  22:5n-3 2.9 ± 0.1a 0.9 ± 0.2c 3.2 ± 0.4a 1.9 ± 0.2b
  22:6n-3 11.8 ± 1.4a 6.5 ± 1.7b 7.9 ± 0.7b 9.2 ± 1.7ab
  Total n-3 PUFA 24.7 ± 1.7 22.2 ± 3.3 25.1 ± 2.4 23.9 ± 3.3
  Total PUFAD 33.2 ± 1.6a 36.2 ± 4.2ab 44.9 ± 3.4a 42.2 ± 4.2ab
  EPA + DHA 19.1 ± 1.8a 8.6 ± 2.3c 14.7 ± 1.4ab 13.2 ± 2.3bc
  EPA/DHA 0.6 ± 0.0b 0.3 ± 0.0d 0.9 ± 0.0a 0.4 ± 0.0c
  EPA + DPA + DHA 22.1 ± 1.9a 9.5 ± 2.5c 17.9 ± 1.8ab 15.1 ± 2.5b
Gills
 Lipid content 10.5 ± 1.5 9.9 ± 1.7 12.1 ± 1.0 11.7 ± 1.5
 Fatty acid composition
  16:0 19.0 ± 0.1a 15.6 ± 0.6b 15.6 ± 0.5b 15.8 ± 0.2b
  Total saturatedA 28.3 ± 0.2a 22.6 ± 0.7b 23.3 ± 0.6b 23.4 ± 0.5b
  18:1n-9 20.4 ± 0.3ab 21.8 ± 0.9a 18.7 ± 0.7b 19.7 ± 0.6b
  Total monounsaturatedB 36.0 ± 0.2a 37.1 ± 1.1a 31.9 ± 0.9b 32.9 ± 0.8b
  18:2n-6 7.2 ± 0.1c 13.4 ± 0.4b 15.1 ± 0.2a 13.8 ± 0.4b
  20:4n-6 0.9 ± 0.1b 0.4 ± 0.0c 1.5 ± 0.1a 1.1 ± 0.0ab
  22:4n-6 0.1 ± 0.0b 0.0 ± 0.0c 0.2 ± 0.0a 0.2 ± 0.0b
  Total n-6 PUFAC 9.2 ± 0.2c 15.4 ± 0.5b 19.4 ± 0.4a 18.4 ± 0.6a
  18:3n-3 1.3 ± 0.0c 11.0 ± 0.6a 4.6 ± 0.3b 5.6 ± 0.3b
  20:5n-3 7.5 ± 0.1a 2.8 ± 0.1c 7.0 ± 0.3a 4.5 ± 0.1b
  22:5n-3 2.8 ± 0.1a 1.3 ± 0.1c 2.7 ± 0.1a 2.2 ± 0.0b
  22:6n-3 10.6 ± 0.2a 6.9 ± 0.5c 7.4 ± 0.2c 8.8 ± 0.3b
  Total n-3 PUFA 24.4 ± 0.3 24.2 ± 1.2 24.7 ± 1.1 24.7 ± 0.2
  Total PUFAD 35.6 ± 0.2c 40.3 ± 1.7b 44.8 ± 1.4a 43.7 ± 0.8a
  EPA + DHA 18.0 ± 0.2a 9.7 ± 0.6d 14.5 ± 0.4b 13.3 ± 0.3c
  EPA/DHA 0.7 ± 0.0b 0.4 ± 0.0d 0.9 ± 0.0a 0.5 ± 0.0c
  EPA + DPA + DHA 20.8 ± 0.2a 11.0 ± 0.6d 17.2 ± 0.6b 15.5 ± 0.3c
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Table 7  Total lipid content 
(percentage of wet weight) and 
fatty acid compositions (mol%) 
of total lipid of anterior intestine 
and brain of sea bream
Data are expressed as mean ± SD (n = 3). Different superscript letters within a row denote significant dif-
ferences among diets as determined by one-way ANOVA with Tukey’s comparison test (p < 0.005)
DCO feed containing EPA + DHA oil from transgenic Camelina, DHA docosahexaenoic acid (22:6n-3), 
DPA docosapentaenoic acid (22:5n-3), ECO feed containing high-EPA oil from transgenic Camelina, EPA 
eicosapentaenoic acid (20:5n-3), FO fish oil feed, WCO wild-type Camelina oil feed
A
 Includes 15:0, 22:0 and 24:0
B
 Includes 16:1n-9 and 24:1n-9
C
 Includes 22:5n-6
D
 Includes C16 PUFA
FO WCO ECO DCO
Anterior intestine
 Lipid content 6.9 ± 1.8 5.0 ± 1.4 4.5 ± 1.0 5.0 ± 0.2
 Fatty acid composition
  16:0 19.7 ± 0.1a 13.4 ± 0.8b 14.6 ± 0.5b 15.0 ± 0.8b
  Total saturatedA 33.1 ± 1.3a 22.1 ± 1.9c 25.3 ± 0.2bc 27.1 ± 1.5b
  18:1n-9 15.3 ± 1.5ab 17.8 ± 1.3a 14.5 ± 0.5ab 8.3 ± 7.0b
  Total monounsaturatedB 30.6 ± 2.5a 32.9 ± 1.7a 26.7 ± 0.6b 31.7 ± 3.8ab
  18:2n-6 5.7 ± 0.8b 15.4 ± 0.6a 16.2 ± 0.7a 16.6 ± 2.1a
  20:2n-6 0.2 ± 0.0c 1.3 ± 0.1a 1.2 ± 0.1a 0.8 ± 0.1b
  20:3n-6 0.2 ± 0.0c 0.2 ± 0.0c 1.0 ± 0.0b 1.3 ± 0.2a
  20:4n-6 1.7 ± 0.4b 0.8 ± 0.2b 3.0 ± 0.2a 2.9 ± 0.7a
  22:4n-6 0.1 ± 0.0b 0.0 ± 0.0c 0.3 ± 0.0a 0.2 ± 0.0a
  Total n-6 PUFAC 8.4 ± 0.4c 18.0 ± 0.5b 22.3 ± 1.0a 24.0 ± 2.3a
  18:3n-3 0.9 ± 0.2c 13.9 ± 1.7a 5.1 ± 0.5b 6.9 ± 1.3b
  20:5n-3 8.1 ± 0.5a 2.6 ± 0.3d 7.0 ± 0.2b 4.2 ± 0.2c
  22:5n-3 2.3 ± 0.2a 1.0 ± 0.1c 2.6 ± 0.3a 1.7 ± 0.1b
  22:6n-3 12.4 ± 2.3a 7.4 ± 1.5b 7.8 ± 0.4b 10.8 ± 1.3ab
  Total n-3 PUFA 25.7 ± 2.1 26.6 ± 0.1 25.1 ± 0.5 26.8 ± 0.9
  Total PUFAD 36.3 ± 1.6c 45.0 ± 0.5b 47.9 ± 0.4ab 51.2 ± 3.1a
  EPA + DHA 20.6 ± 2.6a 9.9 ± 1.8c 14.9 ± 0.6b 15.0 ± 1.1b
  EPA/DHA 0.7 ± 0.1b 0.4 ± 0.0c 0.9 ± 0.0a 0.4 ± 0.1c
  EPA + DPA + DHA 22.9 ± 2.5a 10.9 ± 1.8c 17.5 ± 0.9b 16.8 ± 1.0b
Brain
 Lipid content 9.6 ± 0.2 9.6 ± 0.7 8.9 ± 1.0 8.1 ± 0.2
 Fatty acid composition
  16:0 19.1 ± 0.6 19.3 ± 0.1 18.9 ± 0.8 18.6 ± 1.3
  Total saturatedA 34.3 ± 0.9 34.3 ± 0.3 34.4 ± 0.4 33.9 ± 1.0
  18:1n-9 21.4 ± 0.5a 21.3 ± 0.5a 20.4 ± 0.6ab 20.2 ± 0.5b
  Total monounsaturatedB 34.4 ± 1.1 33.8 ± 0.6 32.7 ± 1.4 32.6 ± 0.7
  18:2n-6 2.0 ± 0.8 2.8 ± 0.5 3.1 ± 0.6 3.5 ± 0.6
  20:2n-6 0.1 ± 0.1b 0.2 ± 0.0a 0.2 ± 0.1a 0.2 ± 0.0a
  20:3n-6 0.1 ± 0.0d 0.2 ± 0.0c 0.3 ± 0.0b 0.4 ± 0.0a
  20:4n-6 1.7 ± 0.1b 1.5 ± 0.1b 2.0 ± 0.1a 2.0 ± 0.1a
  22:4n-6 0.2 ± 0.0ab 0.1 ± 0.0b 0.2 ± 0.0a 0.2 ± 0.0ab
  Total n-6 PUFAC 4.1 ± 0.8b 4.8 ± 0.5ab 5.9 ± 0.7a 6.5 ± 0.7a
  18:3n-3 0.4 ± 0.1b 1.7 ± 0.5a 0.9 ± 0.3ab 1.3 ± 0.3ab
  20:5n-3 4.6 ± 0.3a 3.6 ± 0.2b 4.3 ± 0.1a 3.7 ± 0.1b
  22:5n-3 1.6 ± 0.1a 1.2 ± 0.0b 1.5 ± 0.1a 1.3 ± 0.0b
  22:6n-3 20.0 ± 0.9 20.0 ± 0.5 19.8 ± 0.7 20.1 ± 0.8
  Total n-3 PUFA 27.0 ± 0.5 27.0 ± 0.5 27.0 ± 1.0 27.0 ± 0.3
  Total PUFAD 31.3 ± 0.9 31.9 ± 0.8 32.9 ± 1.6 33.5 ± 0.6
  EPA + DHA 24.6 ± 0.7 23.7 ± 0.8 24.0 ± 0.8 23.8 ± 0.7
  EPA/DHA 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0
  EPA + DPA + DHA 26.2 ± 0.6 24.9 ± 0.8 25.6 ± 0.7 25.1 ± 0.6
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cytoplasmic vacuoles that did not alter hepatocyte shape 
or size (Table 8). Fish fed wild-type Camelina oil (WCO) 
displayed a higher degree of vacuolisation, although no 
structural changes, such as inflammation, necrosis or 
perivascular cuffing were observed. Fish fed the feeds 
containing the GM-derived oils showed intermediate 
levels of vacuolisation, with no differences between FO 
and DCO-fed fish or between WCO and ECO-fed fish 
(Table 8). No significant differences were observed in 
the infiltration of peripancreatic fat although fish fed FO 
showed the lowest scores and DCO-fed fish the highest 
(p = 0.293; Table 8). With intestinal tissue, good integrity 
of the absorptive membrane was observed in the sections 
from fish fed all the dietary treatments. However, cellular 
infiltration, mainly represented by acidophilic granulo-
cytes and some lymphocytes was observed, mainly in fish 
fed ECO (data not shown). Most of the acidophilic granu-
locytes were located in the lamina propria although a few 
could be found in submucosa and were present both in 
mid and hindgut.
Liver and Anterior Intestine Gene Expression
LC-PUFA Biosynthetic Genes
In liver, higher expression of fatty acyl desaturase 2 
(fads2) was observed in fish fed all three diets containing 
VO (WCO, ECO and DCO), with expression significantly 
greater in liver of WCO-fed fish compared to FO-fed fish 
(Fig. 3a). Similarly higher expression in liver of fish fed 
all VO was observed in fatty acid elongase 4 (elovl4), sig-
nificantly so in fish fed both GM-derived oils compared to 
fish fed FO (Fig. 3a). There was also a non-significant trend 
for increased expression of fatty acid elongase 5 (elovl5) in 
fish fed VO diets compared to fish fed FO (Fig. 3a). In con-
trast, anterior intestine showed different nutritional regula-
tion of these genes. Firstly, only elovl4 expression showed 
a similar pattern of expression to that observed in liver with 
higher expression, albeit not significant, in fish fed the VO 
compared to fish fed FO (Fig. 3b). Secondly, fold changes 
(FC) were less with the highest being 1.7 FC for elovl4 for 
ECO-fed fish (Fig. 3b) compared to 4.6 FC in liver for this 
gene in fish fed ECO (Fig. 3a). Only fads2 showed signifi-
cant regulation by dietary oil source, being down-regulated 
in intestine in VO-fed fish compared to fish fed FO, and a 
similar, non significant, trend was found in elovl5 in intes-
tine (Fig. 3b).
Lipid Metabolism Genes
As above, the nutritional regulation of this group of genes 
was more marked in liver (Fig. 4a) than in anterior intes-
tine (Fig. 4b). Lysophosphatidylcholine acyltransferase 
(lpcat) was up-regulated in VO-fed fish in both tissues, 
although the highest expression was found in liver of 
ECO-fed fish, whereas fish fed WCO showed the highest 
significant FC in intestine. Fatty acid binding protein 2 
(FABP2) gene expression was also regulated in liver, with 
highest expression in fish fed ECO, whereas no dietary 
regulation of this gene was observed in anterior intestine. 
Both lipoprotein lipase (lpl) and hepatic lipase (hl) genes 
showed the same pattern in liver, with highest levels of 
expression in fish fed both diets with GM-derived oils, 
with WCO showing intermediate levels between those 
of ECO/DCO and fish fed FO (Fig. 4a). In contrast, no 
regulation was observed in the anterior intestine for lpl, 
although its expression showed a downward trend in 
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Fig. 2  Non-metric multidimensional scaling (NMDS) plot based on 
logarithmically transformed fatty acid composition of liver, muscle, 
gill, anterior intestine and brain from gilthead sea bream fed the four 
dietary treatments for 11 weeks
Table 8  Mean scores for the lipid vacuolisation and peripancreatic 
fat infiltration in liver of gilthead sea bream fed the experimental diets 
for 11 weeks
Data are expressed as mean ± SD (n = 6). Different superscript let-
ters within a row denote significant differences among diets as deter-
mined by one-way ANOVA with Tukey’s comparison test (p < 0.005). 
Scoring was on a scale from 0 to 3 as described in detail in the 
“Materials and Methods” section with 0 = not observed, 1 = few, 
2 = medium, and 3 = severe
DCO feed containing EPA + DHA oil from transgenic Camelina, 
ECO feed containing high-EPA oil from transgenic Camelina, FO 
fish oil feed, WCO wild-type Camelina oil feed
FO WCO ECO DCO
Cytoplasmic lipid 
vacuolisation
0.3 ± 0.3c 2.3 ± 0.7a 1.4 ± 0.7ab 0.8 ± 0.4bc
Peripancreatic fat 0.5 ± 0.4 1.0 ± 0.5 1.0 ± 1.2 1.4 ± 0.7
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Fig. 3  Expression, meas-
ured by qPCR of LC-PUFA 
biosynthesis pathway genes in 
sea bream liver (a) and anterior 
intestine (b) after eleven weeks 
of feeding. Different superscript 
letters denote differences in 
gene expression among the 
treatments according to one-
way ANOVA (p < 0.05). Results 
are normalized expression ratios 
(average ± SEM; n = 6) of the 
expression of these genes in fish 
fed the different diets in rela-
tion to fish fed FO feed. Diets 
contain either fish oil (FO), 
wild-type Camelina oil (WCO), 
high-EPA Camelina oil (ECO) 
or EPA + DHA Camelina oil 
(DCO). fads2, delta-6-fatty acyl 
desaturase; elovl4, fatty acid 
elongase 4; elovl5, fatty acyl 
elongase 5
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Fig. 4  Expression, measured by qPCR of lipid metabolism genes in 
sea bream liver (a) and anterior intestine (b) after 11 weeks of feed-
ing. Different superscript letters denote differences in gene expres-
sion among the treatments according to one-way ANOVA (p < 0.05). 
Results are normalized expression ratios (average ± SEM; n = 6) of 
the expression of these genes in fish fed the different diets in rela-
tion to fish fed FO feed. Diets contain either fish oil (FO), wild-type 
Camelina oil (WCO), high-EPA Camelina oil (ECO) or EPA + DHA 
Camelina oil (DCO). lpcat1, lysophosphatidylcholine acyltransferase 
1; FABP2, fatty acid binding protein 2; hl, hepatic lipase; lpl, lipopro-
tein lipase
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VO-fed fish, and hl could not be detected in intestinal tis-
sue (Fig. 4b).
Fatty Acid Catabolism Genes
Gene expression of two isoforms of carnitine palmitoyltrans-
ferase 1, cpt1a and cpt1b, were evaluated in liver and anterior 
intestine of sea bream (Fig. 5). In general terms, expression 
of both cpt1 in liver was higher in fish fed the VO compared 
to fish fed FO. However, WCO-fed fish showed intermediate 
values of cpt1a expression, lower FC than fish fed ECO, but 
in the same range as DCO-fed fish (Fig. 5a). Fish fed all three 
VO diets showed similar and higher levels of expression of 
cpt1b in liver than fish fed FO. No significant differences in 
expression of either cpt1a or cpt1b were observed in anterior 
intestine of sea bream fed the dietary treatments (Fig. 5b).
Nuclear Receptors
Liver expression of the three evaluated nuclear receptors 
was generally higher in fish fed all of the VO diets com-
pared to fish fed FO, although differences were not sig-
nificant for peroxisome proliferator-activated receptor α 
(PPARα) (Fig. 6a). Expression in liver of PPARγ was high-
est in ECO- and DCO-fed fish with WCO-fed fish show-
ing intermediate values, whereas fish fed all the VO diets 
showed higher expression of sterol regulatory element 
binding protein 1 (srebp1) (Fig. 6a). Although there were 
no significant differences in the expression of these genes 
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Fig. 5  Expression, measured by qPCR of energy metabolism genes 
in sea bream liver (a) and anterior intestine (b) after 11 weeks of 
feeding. Different superscript letters denote differences in gene 
expression among the treatments according to one-way ANOVA 
(p < 0.05). Results are normalized expression ratios (average ± SEM; 
n = 6) of the expression of these genes in fish fed the different diets 
in relation to fish fed FO feed. Diets contain either fish oil (FO), 
wild-type Camelina oil (WCO), high-EPA Camelina oil (ECO) or 
EPA + DHA Camelina oil (DCO). cpt1a, carnitine palmitoyltrans-
ferase, isoform 1a; cpt1b, carnitine palmitoyltransferase, isoform 1b
Fig. 6  Expression, measured 
by qPCR of transcription factor 
genes in sea bream liver (a) 
and anterior intestine (b) after 
11 weeks of feeding. Different 
superscript letters denote differ-
ences in gene expression among 
the treatments according to one-
way ANOVA (p < 0.05). Results 
are normalized expression ratios 
(average ± SEM; n = 6) of the 
expression of these genes in fish 
fed the different diets in rela-
tion to fish fed FO feed. Diets 
contain either fish oil (FO), 
wild-type Camelina oil (WCO), 
high-EPA Camelina oil (ECO) 
or EPA + DHA Camelina oil 
(DCO). PPARα, peroxisome 
proliferator-activated recep-
tor alpha; PPARγ, peroxisome 
proliferator-activated receptor 
gamma; srebp1, sterol regula-
tory element-binding protein 1
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among the dietary treatments in anterior intestine, a con-
sistent pattern of lower expression in fish fed the VO diets 
was observed for all three nuclear receptors (Fig. 6b).
Fish Health and Immune System Genes
Again the three evaluated genes all showed higher expres-
sion in liver of fish fed the VO diets compared to fish fed 
FO (Fig. 7a). In the case of caspase 3 (casp3), ECO-fed 
fish showed the highest expression levels, although no dif-
ferences were found with WCO and DCO-fed fish which 
also showed similar levels of expression to FO-fed fish 
(Fig. 7a). No statistical differences were observed for pro-
liferating cell nuclear antigen (pcna) expression in liver, 
although DCO, and particularly ECO-fed fish, tended to 
have higher levels of expression. DCO-fed fish showed a 
clear up-regulation in hepatic interleukin 8 (il8) expression, 
with WCO and ECO-fed fish displaying intermediate levels 
(Fig. 7a). In contrast, although il8 was also differentially 
regulated by dietary oil source in intestine, the pattern was 
opposite to that observed in liver, with VO-fed fish showing 
lower expression compared to FO-fed fish (Fig. 7b).
Transgenes
All analysed sea bream tissues (muscle, liver and anterior 
intestine) tested negative for the presence of the Camelina 
T-DNA gene construct as monitored by the use of npt-II 
primers (data not shown).
Discussion
The replacement of FO in aquafeeds depends on finding 
alternative, sustainable sources of EPA and DHA, with this 
currently being one of the main issues in aquaculture nutri-
tion, particularly in marine species that have limited abil-
ity for endogenous synthesis of LC-PUFA. Previous trials 
completely replacing FO by VO in feeds for gilthead sea 
bream resulted in reduced growth probably related to a 
reduced intake of essential LC-PUFA, which are not found 
in VO [31–33]. In the present study we evaluated the com-
plete substitution of FO by two different oils obtained from 
GM-oilseed crops rich in either EPA (ECO) or containing 
both EPA and DHA (DCO) in feeds for sea bream juve-
niles. Both oils proved to be effective substitutes of FO, 
displaying growth rates that were similar to those achieved 
by fish fed FO (in the case of DCO) or WCO (for ECO). 
Similarly, recent studies employing both oil iterations as 
substitutes for FO in Atlantic salmon feeds showed that fish 
fed these oils were as successful as those fed FO [13, 15]. 
The lack of effect on growth in WCO-fed fish in the present 
trial is explained by the inclusion of relatively high lev-
els of FM which ensured that n-3 LC-PUFA requirements 
were fully satisfied (1.9 % n-3 LC-PUFA in WCO-feed), 
estimated to be 0.9 % of dry feed [34].
It was surprising that the ECO-fed fish showed slightly 
reduced performance, albeit no different to WCO-fed fish, 
given that n-3 LC-PUFA requirements, including DHA, 
were satisfied. One reason for this could be related to the 
Fig. 7  Expression, measured 
by qPCR of fish health and 
immune system genes in sea 
bream liver (a) and anterior 
intestine (b) after 11 weeks of 
feeding. Different superscript 
letters denote differences in 
gene expression among the 
treatments according to one-
way ANOVA (p < 0.05). Results 
are normalized expression ratios 
(average ± SEM; n = 6) of the 
expression of these genes in fish 
fed the different diets in rela-
tion to fish fed FO feed. Diets 
contain either fish oil (FO), 
wild-type Camelina oil (WCO), 
high-EPA Camelina oil (ECO) 
or EPA + DHA Camelina oil 
(DCO). casp3, caspase 3; pcna, 
proliferating cell nuclear anti-
gen; il8, interleukin 8
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
FO WCO ECO DCO
casp3
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
FO WCO ECO DCO
pcna
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
FO WCO ECO DCO
il8
b
a
ab
ab
b
ab
a
ab
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
FO WCO ECO DCO
casp3
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
FO WCO ECO DCO
pcna
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
FO WCO ECO DCO
il8
b
b
a
b
A
B
 Lipids
1 3
balance between the different dietary LC-PUFA includ-
ing the dietary EPA/DHA ratio, which differed among the 
feeds. An EPA/DHA ratio of 2:1 was reported to be optimal 
for sea bream juveniles [35] and in the present trial ECO 
feed presented a ratio of approximately 3:1, perhaps sug-
gesting an imbalance in these essential fatty acids. How-
ever, in previous trials in Atlantic salmon, where the EPA/
DHA ratio was even higher (around 9:1), given the higher 
oil inclusion and lower FM level, no adverse effect was 
observed on growth [13]. However, it should be noted that 
the optimal dietary EPA/DHA ratio is likely to be species-
specific. Another fatty acid that differed between ECO and 
the other feeds was ARA, with the ECO diet having more 
than double the ARA content of the FO diet. Increased die-
tary ARA levels have been associated with enhanced stress 
resistance, survival and improved growth in sea bream 
juveniles and larvae [36–40] as occurs in other marine 
warm water species such as European sea bass (Dicentrar-
chus labrax) [41]. However, ARA produces pro-inflamma-
tory effects due to production of prostaglandin E2 (PGE2), 
leukotriene B4 (LTB4) and lipoxins [42], and so diets rich 
in n-6 PUFA, primarily ARA, could lead to overproduction 
of PGE2 although that can, in turn, have an immunosup-
pressant effect [43]. Although no major or obvious altera-
tion in fish health was shown by the histology and qPCR 
results in the present study, increased ARA levels or even 
imbalanced proportions of n-3 and n-6 PUFA may partly 
explain the slightly lower growth of ECO-fed sea bream. 
On the other hand, the ratios of ARA, EPA and DHA to 
each other are also known to be of importance for marine 
finfish nutrition. For instance, a diet with high EPA and low 
ARA (9:1) significantly reduced performance of Atlantic 
salmon when compared to fish fed a more balanced ratio of 
EPA and ARA (1.5:1) [44], similar to what was observed in 
the present trial. Additionally, multiple regression analysis 
demonstrated meaningful relationships between ARA and 
DHA in California yellowtail (Seriola dorsalis) with ARA 
and DHA contributing positively to weight gain whereas 
EPA contributed negatively [45]. Thus, the lower growth 
observed in ECO-fed sea bream could be due to imbal-
anced proportions between these three essential LC-PUFA.
Despite the slightly reduced performance of ECO-fed 
fish compared to FO and DCO-fed fish, no marked differ-
ences were observed in lipid or individual fatty acid digest-
ibility, which is consistent with previous studies in salmon 
using the same oil [14]. However, ECO-fed fish consumed 
less feed (g/tank) than fish fed FO or WCO diets, which 
may suggest a palatability issue with this oil. However, it 
must be noted that both oils were extracted using the same 
process and stabilized using the same concentration of anti-
oxidant (ethoxyquin). In addition, exactly the same batch 
of ECO was used in the earlier trial in salmon where no dif-
ferences in performance were observed between treatments 
[13]. Moreover, the sea bream feeds were formulated with 
higher FM levels than the earlier salmon feeds, which 
would in turn be expected to increase palatability. Thus, it 
appears that the slightly reduced performance of ECO-fed 
fish is more likely to be related to a species-specific sen-
sitivity to high dietary ARA/n-6 levels that affected feed 
intake rather than a problem with palatability.
Complete substitution of dietary FO by VO is also asso-
ciated with increased deposition of C18 fatty acids and 
reduced proportions of LC-PUFA in fish tissues. The two-
GM derived oils investigated in the present trial can be 
considered as “hybrid” oils given that they contain features 
of both vegetable and marine oils, and the tissue fatty acid 
profiles reflected this characteristic. Thus, in general terms 
tissues of ECO and DCO fed fish had higher proportions 
of n-3 LC-PUFA than fish fed WCO, which in the case of 
flesh enhanced the nutritional value of the product. Some 
limited biosynthetic activity was observed particularly in 
fish fed ECO with high EPA (and ARA), where higher lev-
els of DPA (22:5n-3) and 22:4n-6 were observed in liver, 
muscle and gills compared to fish fed either WCO or DCO. 
This likely reflected the higher hepatic expression of elovl4, 
an enzyme that participates in the elongation of ARA and 
EPA to 22:4n-6 and 22:5n-3, respectively [46], observed in 
ECO and DCO-fed fish. However, the increased expression 
of fads2 was not statistically significant in ECO fed fish, 
which showed intermediate values between FO and WCO-
fed fish. However, increased expression of fads2 has been 
reported previously in sea bream fed VO compared to fish 
fed FO [21, 22]. The involvement of elovl4 in only later 
stages of the biosynthetic pathway (predominantly elonga-
tion of C22), particularly the synthesis of very long chain 
fatty acids (VLC-FA), explains why sea bream tissue fatty 
acid compositions largely reflected dietary fatty acid com-
positions. This was clear in the PCA (NMDS Plot) analysis 
where all tissues, except brain, grouped according to the 
feeds, with ECO and DCO clustering in the same group. 
This indicated that the fatty acid composition of brain was 
more conserved and less affected by diet than the other tis-
sues, consistent with other studies in the same species [20] 
and other teleost species [47, 48].
Inclusion of high levels of VO and reduction of FO in 
feeds has been associated with increased tissue lipid dep-
osition in several fish species [13, 14, 33, 49–51]. In the 
present study increased lipid deposition was observed 
only in liver, being highest in WCO-fed fish with ECO 
and DCO-fed fish showing intermediate values, with 
liver histology following the same trend. Similar results 
were found in Atlantic salmon fed high ECO, reflect-
ing the hybrid nature of the GM-derived oil [13, 14]. The 
mechanism for increased lipid deposition in fish fed VO 
is not clear although high n-3 LC-PUFA levels found in 
FO can suppress triacylglycerol (TAG) accumulation in 
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mammalian pre-adipocytes [52] and lipid accumulation in 
Atlantic salmon adipocytes [53]. Another explanation for 
the enhanced lipid deposition could be the high levels of 
both C18 fatty acids, 18:2n-6 and 18:3n-3, together with 
the limited LC-PUFA biosynthetic capacity of this species 
[22]. In the present study we evaluated the expression of 
genes involved in lipid and energy metabolism, as well as 
transcription factors such as SREBP1, which plays a key 
role in lipid metabolism participating in fatty acid metabo-
lism and de novo lipogenesis [54]. Up-regulation in srebp1 
expression in liver was observed in fish fed the three VO in 
agreement with studies carried out in elovl5−/− mice that 
indicated low levels of EPA and DHA lead to activation 
of this transcription factor [55]. Similar results have been 
obtained in other fish species when fed low levels of n-3 
LC-PUFA or VO [50, 56–58]. Up-regulation of srebp1 in 
VO-fed fish could lead to the regulation of srebp1 target 
genes such as fads2, hl, lpl, cpt1a and cpt1b. Hydrolysis 
of TAG in lipoproteins is mediated by lpl, and hl converts 
intermediate density lipoprotein to low density lipoprotein, 
mediating uptake of fatty acids by tissues. Thus, enhanced 
expression of these two lipase genes would enhance lipid 
deposition in liver in agreement with a previous study in 
turbot (Scophtalmus maximus) fed soybean oil [50]. On 
the other hand, cpt1a, a gene involved in fatty acid oxida-
tion was up-regulated in fish fed the GM-derived oils and, 
although it is a srebp1 target gene, down-regulation of this 
gene was expected [50]. However, in comparison to the 
clear effects on liver cpt expression in the present study, 
published data show only marginal effects of replacing FO 
by VO on β-oxidation [59, 60]. In addition, there are other 
nutrients that can affect the regulation of these genes such 
as carbohydrate that can affect lipid metabolism, enhancing 
the expression of srebp1 and cpt1a and cpt1b in rainbow 
trout (Oncorhynchus mykiss) when fed VO [18].
Two other transcription factors, PPARα and PPARγ, 
that regulate lipid metabolism and energy homeostasis [61] 
were evaluated in the present trial, but no regulation of 
pparα was noted in either liver or anterior intestine. PPARα 
activation by n-3 LC-PUFA may induce the expression of 
lipolytic genes, such as cpt, enhancing fatty acid oxidation 
[62]. However, in the present study and others, no regula-
tion of pparα expression has been observed in fish fed more 
sustainable diets based on VO [50, 63–65]. In contrast, 
feeding VO, particularly the GM-derived oils, increased 
pparγ expression. PPARγ activation in mice is known to 
increase glycolysis, fat storage, fatty acid desaturation and 
elongation [66]. Thus, up-regulation of pparγ may be a 
compensatory mechanism to attenuate the increased lipid 
deposition found in fish fed high levels of VO, although it 
did not have a direct effect on lipolytic genes. Consistent 
with this, pparγ expression was up-regulated in mice fed 
the high-EPA oil (ECO) compared to mice fed a FO-based 
diet [67].
Acyltransferases such as LPCAT play a major role in 
phospholipid remodelling as they alter the fatty acid com-
position of phospholipids at the sn-2 position [68]. The 
expression of this gene tended to increase in VO-fed fish 
compared to FO-fed fish in both liver and intestine. This 
could be reflected in enhanced conversion of lysophos-
phatidylcholine to phosphatidylcholine in VO-fed fish. 
Although there is only limited information regarding the 
regulation of this gene in teleosts, n-3 PUFA have been 
found to regulate lcpat1 in larvae of Senegalese sole (Solea 
senegalensis), where gene expression was up-regulated in 
larvae fed diets containing linseed oil compared to other 
sources of VO, although no differences were observed with 
fish fed FO [69]. It is difficult to make comparisons with 
this study, as fast growing larvae have a high requirement 
for dietary phospholipids [70] but it is clear that nutritional 
regulation by n-3 PUFA or LC-PUFA occurs regardless of 
the life stage. In fact, lpcat1 regulation has also been found 
in sea bream [71] and sea bass [72] subjected to fasting, 
although the direction of regulation varied among spe-
cies. Also fabp2, a gene related to fatty acid transport and 
uptake, was regulated in liver, being clearly up-regulated in 
fish fed ECO. Similarly, Atlantic cod (Gadus morhua) fed 
plant meal diets showed a trend towards up-regulation of 
fabp2 compared to fish fed fishmeal, in this case associated 
with lower fat digestibility of the plant-based feeds [73]. 
Although we cannot fully explain this result at present, we 
suggest that the up-regulation may be associated with the 
lower growth of these fish, which in turn could elicit com-
pensatory mechanisms such as fatty acid mobilization.
Some genes were analysed in order to evaluate the 
immune system and fish health in response to dietary oils. 
Caspases are central regulators of apoptosis, while PCNA 
is a marker of cell proliferation, also expressed in non-
dividing cells undergoing DNA synthesis and repair [74]. 
In previous studies, expression of caspases was affected 
by replacement of dietary FO by VO in fish [63, 64, 75]. 
Apoptosis is particularly important in tissues with high 
cell turnover rate such as liver [76] but, in addition, their 
expression can be altered by factors such as pathological 
or toxic conditions [77]. Certain VO have been found to 
enhance oxidative stress and cellular damage [78], and 
DHA can suppress caspase 3 activation and cell death in 
neurons [79], which suggests FO diets could have a cel-
lular protective effect in fish. In contrast, the lack of 
nutritional regulation in anterior intestine was consistent 
with the results observed in sea bass fed diets contain-
ing soybean oil [80]. Expression of pcna was not altered 
when fish were fed the VO-feeds consistent with a previ-
ous study in Atlantic salmon [75]. Interleukin 8 (il8), a 
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cytokine that serves as a chemical messenger in innate and 
adaptive immune systems, showed differential regulation 
in liver and intestine of fish fed VO, probably related to 
the specific functions of each tissue and their response to 
nutritional challenge. In this respect, fish gut epithelium 
acts and reacts as the first line of protection against poten-
tially harmful substances in the diet, with VO causing 
changes in fish that could favour intestinal dysfunction, 
including alterations in the gut associated immune system 
[81]. Thus, down-regulation of il8 in intestine of VO-fed 
fish confirmed the importance of dietary fatty acid profile 
on the immune system of marine fish in agreement with 
previous studies [80, 82]. In contrast, liver of DCO-fed 
fish showed higher expression of il8, albeit not different to 
expression in liver of bream fed the other VO diets, which 
may indicate that the VO fatty acid profile may enhance il8 
activity in this tissue.
In summary, both genetically engineered Camelina 
oils (EPA only or EPA + DHA) were shown to be via-
ble sources of n-3 LC-PUFA and potential candidates to 
replace FO in feeds for sea bream, with the growth of fish 
fed DCO similar to that of fish fed FO. Both oils improved 
the nutritional quality of the fish fillet, enhancing the n-3 
LC-PUFA levels compared to the fish fed the regular (wild-
type) VO. Limited LC-PUFA biosynthesis was observed, 
specifically in liver of fish fed ECO, reflected in higher 
levels of n-3 DPA, consistent with increased expression of 
elovl4 elongase. In general, gene expression reflected the 
“hybrid” fatty acid composition of the GM-derived oils, 
eliciting responses that were between the levels of expres-
sion in FO and WCO-fed fish, although often more similar 
to WCO. This may suggest the importance of not only EPA 
and DHA, but also C18 PUFA levels in marine fish lipid 
metabolism. Based on histology and gene expression, no 
adverse effects on fish health were observed and thus the 
cause for the slight reduction in feed intake and consequent 
fish growth observed in fish fed ECO was not clear but may 
be related to dietary ARA levels and/or LC-PUFA ratios. 
Longer term trials with fish up to market size are required 
to further validate the feasibility of oils from transgenic oil-
seed crops in marine fish aquaculture.
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